Skip to Content

R 725 (Montelukast sodium 10 mg (base))

Pill imprint R 725 has been identified as Montelukast sodium 10 mg (base).

Montelukast is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma; copd and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Montelukast 10 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Montelukast sodium 10 mg (base) R 725
Montelukast sodium 10 mg (base) R 725 Front
Montelukast sodium 10 mg (base) R 725 Back
Montelukast sodium 10 mg (base) R 725
Montelukast sodium
Imprint:
R 725
Strength:
10 mg (base)
Color:
Brown
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Leukotriene modifiers
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Dr.Reddy's Laboratories Limited
National Drug Code (NDC):
55111-0725
Inactive Ingredients:
croscarmellose sodium
hydroxypropyl cellulose
lactose monohydrate
magnesium stearate
microcrystalline cellulose
hypromelloses
ferric oxide yellow
ferrosoferric oxide
ferric oxide red
polyethylene glycol 400
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
68084-0875 Amerisource Health Services

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide